Keyphrases
Receptor for Advanced Glycation End Products
100%
Liver Carcinogenesis
100%
Cell Activation
100%
Cell Inflammation
100%
Oval Cells
100%
Mdr2
40%
Inflammation
30%
Mouse Model
20%
Hepatocellular Carcinoma
20%
Liver
20%
High Mobility Group Box 1 (HMGB1)
20%
Tumor
10%
Tumor Metastasis
10%
Tumor Progression
10%
Novel Functions
10%
Ablation
10%
Pharmacologic
10%
ERK2
10%
Inflammatory Response
10%
Chronic Inflammatory Diseases
10%
Enhanced Expression
10%
Liver Damage
10%
Liver Fibrosis
10%
Immunoglobulin Superfamily
10%
Study Support
10%
Tissue Damage
10%
Protein Mobility
10%
Cyclin D1 (CCND1)
10%
Tumor Development
10%
Cell Tumor
10%
Proliferation in Vitro
10%
Human Pathology
10%
S100 Proteins
10%
Rage
10%
Dietary Regime
10%
Preneoplastic
10%
Choline-deficient
10%
Damage-associated Molecular Patterns
10%
Ethionine
10%
Prototype Model
10%
Multiligand
10%
Oval Cell Proliferation
10%
Medicine and Dentistry
Advanced Glycation End Product Receptor
100%
Liver Carcinogenesis
100%
Cell Activation
100%
Hepatocellular Carcinoma
20%
Neoplasm
10%
Tumor Progression
10%
In Vitro
10%
Metastatic Carcinoma
10%
Choline
10%
Cell Proliferation
10%
Serositis
10%
Receptor
10%
Tissue Injury
10%
Liver Fibrosis
10%
Liver Injury
10%
Immunoglobulin
10%
Inflammatory Disorder
10%
Cyclin D1
10%
Mitogen Activated Protein Kinase 3
10%
S-100 Protein
10%
Ethionine
10%
Rage
10%
Tumor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Liver Carcinogenesis
100%
Advanced Glycation End Product Receptor
100%
Mouse Model
20%
Liver Cell Carcinoma
20%
Neoplasm
10%
Tumor Growth
10%
Choline
10%
Receptor
10%
Tissue Injury
10%
Liver Fibrosis
10%
Liver Injury
10%
Cyclin D1
10%
Protein S 100
10%
Mitogen Activated Protein Kinase 3
10%
Immunoglobulin
10%
Ethionine
10%
Immunology and Microbiology
Glycation
100%
Cell Activation
100%
Mouse Model
20%
Inflammatory Disorder
10%
Cell Proliferation
10%
Inflammation Response
10%
Immunoglobulin Superfamily
10%
Cyclin D1
10%
In Vitro
10%